HALO Michael J Labarre sells $587K worth of shares
Feb 28, 2025, 5:31 AM
0.00%
What does HALO do
Halozyme Therapeutics, a San Diego-based biopharmaceutical company, specializes in drug delivery technology and has two proprietary products, Hylenex and XYOSTED, focusing on subcutaneous administration. Founded in 2003, it employs 373 people and partners with other firms for drug-device combinations.
Michael J Labarre sold 10,000 shares of HALO on 25 February at $58.67 per share, worth a total of $587K. They now own 186,153 HALO shares, or a 5% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
